Ultime notizie per S4 Capital (OTC:SCPPF) Azioni

S4 Capital PLC is a company whose principal business activities are focused on the provision of new age/new era digital advertising and marketing services. It builds a purely digital advertising and marketing services business for global, multinational, regional, and local clients and millennial-driven influencer brands. The company integrates businesses in three practice areas: First-Party Data, Content, and Programmatic. Along with an emphasis on faster, cheaper executions in an always-on consumer-led environment, with a unitary structure. The company operates in three reportable segments Content practice, Data&Digital Media practice, and Technology Services practice.

S4 Capital PLC

Baird analyst Mike Polark maintains Inspire Medical Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INSP#NYSE">INSP</a>) with a Outperform and raises the price target from $230 to $236.

News

Price Target

Analyst Ratings

INSP

Baird Maintains Outperform on Inspire Medical Systems, Raises Price Target to $236

XPEL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XPEL#NASDAQ">XPEL</a>) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.27 by 14.81 percent. This is a 6.9 percent increase over earnings of $0.29 per share from the same period last year. The company reported quarterly sales of $103.81 million which beat the analyst consensus estimate of $97.40 million by 6.58 percent. This is a 15.21 percent increase over sales of $90.10 million the same period last year.

Earnings

Earnings Beats

XPEL

XPEL Q1 EPS $0.31 Beats $0.27 Estimate, Sales $103.81M Beat $97.40M Estimate

Macro Economic Events

Econ #s

Economics

USA Exports (March) 278.50B; 278.50B Prior

Baird analyst Joel Beatty maintains Axsome Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXSM#NASDAQ">AXSM</a>) with a Outperform and raises the price target from $160 to $162.

AXSM

Baird Maintains Outperform on Axsome Therapeutics, Raises Price Target to $162

KBR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBR#NYSE">KBR</a>) affirms FY2025 Adj EPS guidance from $3.71-$3.95 to $3.71-$3.95 vs $3.80 analyst estimate. Affirms FY2025 sales outlook from $8.70 billion-$9.10 billion to $8.70 billion-$9.10 billion vs $8.84 billion estimate.

Guidance

KBR Affirms FY2025 Adj EPS Guidance of $3.71-$3.95 vs $3.80 Est; Affirms FY2025 Sales Guidance of $8.70B-$9.10B vs $8.84B Est

Baird analyst Jonathan Komp maintains Wolverine World Wide (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WWW#NYSE">WWW</a>) with a Outperform and raises the price target from $15 to $20.

Baird Maintains Outperform on Wolverine World Wide, Raises Price Target to $20

US Imports (Mar) $419B: Prior $401.10B

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is down 0.5% over the past 24 hours as traders eye a potential local top one day before the Federal Reserve announces <a href="https://www.benzinga.com/25/05/45192387/market-bets-on-aggressive-fed-cuts-clash-with-short-rate-market-data-next-fed-chair-could-initiate-cutting-cycle-says-expert">its interest rate decision</a>
What Happened: Crypto trader Astronomer <a href="https://x.com/astronomer_zero/status/1919485112150065533?s=46">said</a> on Tuesday there's a chance Bitcoin may form a short-term top around the FOMC meeting. 
He cautions this signal is weak by itself and shouldn&#8217;t trigger trades without supporting data. 
The keyword is "may," reiterating his approach of acting only on firm signals and logic-based setups.
While FOMC events have historically triggered >85% accurate reversals, this time the strong quarterly uptrend could override that pattern. 
Astronomer estimates a 76% probability that BTC continues upward from current levels, with a 24% chance of a shallow pullback.
He warns against shorting here or prematurely exiting longs, framing any dip as a "compound opportunity" rather than a reason to panic.
The strategy remains focused, mentally prepared, and rooted in strong trade management consistent about earlier theories on price mechanics and stop-loss design.
Also Read: <a href="https://in.benzinga.com/markets/cryptocurrency/25/05/45191302/corporations-will-pour-330-billion-into-bitcoin-by-2029-bernstein">Corporations Will Pour $330 Billion Into Bitcoin By 2029: Bernstein</a>
What's Next: Crypto trader Titan of Crypto notes BTC is consolidating between last week's high and low ahead of the FOMC decision and Fed Chair Jerome Powell's speech. 
The daily MACD has flipped bearish, suggesting momentum may be fading.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> Short-Term Update &#x1f4a5;<a href="https://twitter.com/hashtag/BTC?src=hash&amp;ref_src=twsrc%5Etfw">#BTC</a> is consolidating between last week's high and low, awaiting tomorrow's FOMC meeting and Jerome Powell's speech. Meanwhile, the daily MACD is crossing bearish, signaling slowing momentum. <a href="https://t.co/UKA0Vjj5xB">pic.twitter.com/UKA0Vjj5xB</a>
&mdash; Titan of Crypto (@Washigorira) <a href="https://twitter.com/Washigorira/status/1919702726235111538?ref_src=twsrc%5Etfw">May 6, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
PattaTrades <a href="https://x.com/PattaTrades/status/1919711436617502760">highlights </a>that Bitcoin is trading back within a six-day composite range from before the monthly close. 
He's eyeing a potential sweep below $63,850 for long liquidations before entering new longs.
He expects muted volatility until after the FOMC, with range-bound setups preferred in the short term.  
Read Next:
<ul>
<li><a href="https://in.benzinga.com/markets/cryptocurrency/25/05/45196732/bitcoin-could-hit-450000-raoul-pal-says-dont-screw-this-up">Bitcoin Could Hit $450,000, Raoul Pal Says: &#8216;Don&#8217;t Screw This Up&#8217;</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin Dips Below $94,000 As Traders Eye Potential Short-Term Top

US Mar. Trade Balance $(140.50B) vs $(136.80B) Est.; Prior $(123.20B)

Baird analyst Michael Bellisario maintains Wyndham Hotels &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WH#NYSE">WH</a>) with a Outperform and lowers the price target from $107 to $99.

Baird Maintains Outperform on Wyndham Hotels & Resorts, Lowers Price Target to $99

IREN Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>) (together with its subsidiaries, "IREN" or "the Company"), today published its monthly update for April 2025.
April&nbsp;Highlights
<ul>
<li>Mining capacity increased to 40 EH/s mid-month</li>
<li>On track for 50 EH/s&nbsp;by June 30</li>
<li>Miners scheduled to ship from Southeast Asia (during 90-day pause on reciprocal tariffs)</li>
<li>AI Cloud Services revenue continuing to&nbsp;grow</li>
<li>Horizon 1 AI Data Center on track for H2 2025 delivery</li>
<li>Customer and financing workstreams progressing</li>
</ul>

IREN

IREN Shares April 2025 Monthly Update; Mining Capacity Increased To 40 EH/s Mid-Month, On Track For 50 EH/s By June 30

Baird analyst Peter Benedict maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Outperform and lowers the price target from $125 to $115.

FRPT

Baird Maintains Outperform on Freshpet, Lowers Price Target to $115

Needham analyst Ami Fadia reiterates Harmony Biosciences Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRMY#NASDAQ">HRMY</a>) with a Buy and maintains $49 price target.

Reiteration

HRMY

Needham Reiterates Buy on Harmony Biosciences Hldgs, Maintains $49 Price Target

<a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1543151/000155278125000160/e25191_uber-8k.htm" title="https://www.sec.gov/ix?doc=/Archives/edgar/data/1543151/000155278125000160/e25191_uber-8k.htm">https://www.sec.gov/ix?doc=/Archives/edgar/data/1543151/000155278125000160/e25191_uber-8k.htm</a>

UBER

Uber Technologies To Acquire 85% Controlling Stake In Trendyol GO Online Meal And Grocery Delivery Business In Turkiye For ~$700M

Small Cap Consumer Research analyst Eric Beder reiterates a.k.a. Brands Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AKA#NYSE">AKA</a>) with a Buy and maintains $30 price target.

Small Cap Consumer Research Reiterates Buy on a.k.a. Brands Holding, Maintains $30 Price Target

WIIM

DDOG

DDOG stock has given up its prior gain. Datadog shares were trading higher after the company reported better-than-expected Q1 results and raised its FY25 guidance.

Billionaire investor Bill Ackman isn't just writing a $900 million check to Howard Hughes Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HHH#NYSE">HHH</a>) &#8211; he's rewriting the script.
In a move that caught Wall Street's eye, Pershing Square, backed mainly by Ackman himself, is investing in Howard Hughes at $100 a share &#8211; a 48% premium over its May 2 close of $67.47. The punchline? Ackman's not going for a full buyout. Instead, he's installing himself as executive chairman and bringing his trusted lieutenant Ryan Israel along as chief investment officer.
Related: <a href="https://www.benzinga.com/25/05/45199902/bill-ackman-strikes-deal-to-form-mini-version-of-berkshire-hathaway-a-free-money-generating-company-he-wouldnt-bet-against">Bill Ackman Aims To Mimic Buffett, Berkshire Blueprint With $900M Howard Hughes Bet</a>
For Ackman, this is more than just a financial play – it's about transforming Howard Hughes into a diversified holding company, with future acquisitions likely in industries like insurance. While the real estate game remains Howard Hughes's core, Ackman aims to breathe new life into the company, one strategic deal at a time.
JPMorgan analyst Anthony Paolone is bullish on the stock, calling this deal a transformational shift. The new agreement cuts Pershing's annual fees to a modest $15 million, down from the previous proposal's $60 million, while linking additional fees to actual equity growth. With a target price of $82, Ackman could earn $29 million – half of what the previous plan would have cost. But there's a catch: Howard Hughes's real estate assets remain tough to value, and the stock will likely continue to trade below its net asset value (NAV), pegged at $90 by JPMorgan.
So, while Ackman may have a playbook, will he be able to execute it? That's the $900 million question.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0506"><img loading="lazy" decoding="async" width="633" height="489" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06061641/Screenshot-2025-05-06-at-3.46.28-PM.png" alt="" class="wp-image-902951" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06061641/Screenshot-2025-05-06-at-3.46.28-PM.png 633w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06061641/Screenshot-2025-05-06-at-3.46.28-PM-300x232.png 300w" sizes="(max-width: 633px) 100vw, 633px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0506">Chart created using Benzinga Pro</a>
On the technical side, Howard Hughes is showing mixed signals. The stock price is currently $69.40, above the 8-day simple moving average (SMA) of $67.75, suggesting short-term bullish momentum. The 20-day SMA of $66.43 also signals a positive outlook.
The 50-day SMA of $71.34 and the 200-day SMA of $74.94 point to bearish pressure in the longer term. The Moving Average Convergence Divergence (MACD) indicator is at a negative 0.91, signaling a bearish outlook, while the Relative Strength Index (RSI) at 53.09 suggests a neutral stance.
In short, Howard Hughes is caught between bullish short-term signals and bearish longer-term pressure. To gauge the next move, traders will need to watch for a break above the 50-day SMA or a dip below the 200-day SMA.
Keep an eye on the stock as Ackman's strategy unfolds. The earnings report on May 7 will be the next key test.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45193861/3-stocks-warren-buffett-first-bought-24-years-ago-hint-apples-not-one-of-them">3 Stocks Warren Buffett First Bought 24 Years Ago (Hint: Apple&#8217;s Not One Of Them)&#8217;</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Hedge Funds

Technicals

Previews

Trading Ideas

Bill Ackman's $900M Boost Could Lift Howard Hughes Stock Above Key Technical Barrier Ahead Of Q1 Earnings

Embraer-Empresa Brasileira De Aeronautica

Embraer Affirms FY25 Sales Guidance Of $7.00B-$7.50B vs $7.34B Estimate

Biotech

Legal

General

WINT

Windtree Therapeutics Received Advice From Intellectual Property And FDA Experts; Istaroxime May Receive New Chemical Entity Designation; Istaroxime Has USPTO Issued Method Of Patent Providing Protection Until 2039 And Pedning Method Of Using Patent Providing Protection Until 2043

Embraer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ERJ#NYSE">ERJ</a>) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $0.03 by 1433.33 percent. This is a 471.43 percent decrease over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $1.10 billion which missed the analyst consensus estimate of $1.18 billion by 6.63 percent. This is a 23.02 percent increase over sales of $896.60 million the same period last year.

Comments

S4 Capital

Notizie

Ultime notizie per S4 Capital (OTC:SCPPF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO